ALVARO ORJUELA to Remission Induction
This is a "connection" page, showing publications ALVARO ORJUELA has written about Remission Induction.
Connection Strength
0.197
-
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study. Arthritis Care Res (Hoboken). 2025 Apr; 77(4):504-512.
Score: 0.053
-
Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis. Pediatr Nephrol. 2024 Oct; 39(10):2959-2968.
Score: 0.051
-
International cohort of 382 children with lupus nephritis - presentation, treatment and outcome at 24?months. Pediatr Nephrol. 2023 11; 38(11):3699-3709.
Score: 0.048
-
Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis. Rheumatology (Oxford). 2022 05 30; 61(6):2563-2571.
Score: 0.045